VIAD PHARMA ApS: Financial statements 2017
CVR: 36433892
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,537,937 and a net result of DKK 676,743 compared with DKK 623,135 the year before. That is an increase of 6.6% compared with the year before. Equity in the 2017 report amounted to DKK 760,941. The solvency ratio was 68%.
- Gross Profit
- DKK 1,537,937
- Profit/Loss
- DKK 676,743
- Equity
- DKK 760,941
- Total Assets
- DKK 1,119,166
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.5 mio. | 677 t. | 761 t. | - |
| 2016 | - | 1.4 mio. | 623 t. | 684 t. | - |
Official annual report
Keep an eye on VIAD PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
VIAD PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 1,442,424, and the net result was DKK 623,135.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.